This advertising blitz and the recent appearance of lawsuits against the manufacturers of these drugs signals the coming of protracted and widespread multidistrict and mass tort litigation over these products.
Estimated spending on these ads increased by nearly 1200% over spending in January.
Most of the TV ads referred to testosterone treatments generally -- although some mentioned the market leader AndroGel (AbbVie) and Axiron (Lilly) by name.
Video of some recent attorney testosterone ads are below:
| || |